Pain medication is one of the most common causes of stomach problems worldwide, ranging from mild heartburn and nausea to bleeding ulcers that require hospitalization. Non-steroidal anti-inflammatory drugs, the class that includes ibuprofen, naproxen, and aspirin, are the biggest culprits, but opioids and even some newer pain-management approaches carry their own gastrointestinal risks. The connection between these drugs and your gut is more complex than “they irritate your stomach,” and it involves biology that makes certain people far more vulnerable than others.
How NSAIDs Damage the Stomach Lining
Your stomach has a built-in defense system: a thick layer of mucus, a steady supply of bicarbonate to neutralize acid, and robust blood flow to the lining that helps repair everyday wear. These defenses depend on chemicals called prostaglandins. NSAIDs work by blocking the enzymes that produce prostaglandins, which is exactly why they reduce pain and inflammation. The problem is that the same prostaglandins that drive inflammation in your sore knee are also the ones keeping your stomach lining intact.
When you take an NSAID, mucus production drops, bicarbonate secretion slows, blood flow to the stomach wall decreases, and damaged cells regenerate more slowly. The result is a lining that can no longer protect itself against its own acid. This is why NSAIDs are considered a major cause of peptic ulcer disease and its complications.1PubMed Central. Peptic ulcer disease and non-steroidal anti-inflammatory drugs There is also a direct local irritant effect: the drug physically contacts the stomach lining and causes topical damage, though the systemic enzyme-blocking mechanism does most of the harm.
This damage is not confined to people who take large doses. Even over-the-counter ibuprofen or naproxen at recommended doses can cause erosions or ulcers, particularly with regular use over weeks or months. And because the damage often builds silently, many people have no symptoms until something serious happens, like a bleeding ulcer.
Aspirin Carries Its Own Risk
People often think of aspirin as gentler than other pain medications because it has been around for over a century and is widely recommended for heart health. But aspirin is an NSAID, and it damages the stomach through the same prostaglandin-blocking mechanism. Even at the low doses used for cardiovascular prevention, aspirin raises the risk of gastrointestinal bleeding. A large study of women followed over many years found that regular aspirin users had roughly a 40 to 70 percent higher risk of gastrointestinal bleeding compared to non-users, depending on the site of bleeding. The risk climbed steeply with higher doses: women taking more than 14 standard tablets per week had about double the risk, even after accounting for how long they had been taking it.2PubMed Central. Long Term Use of Aspirin and the Risk of Gastrointestinal Bleeding
Older adults on long-term low-dose aspirin for heart disease are a particularly vulnerable group, since both age and extended use independently increase the likelihood of upper gastrointestinal bleeding.3Indonesian Journal of Pharmacology and Therapy. Factors influencing upper gastrointestinal bleeding in geriatric coronary heart disease patients taking low-dose aspirin If your doctor has you on daily aspirin for your heart, the benefit usually outweighs the gut risk, but it is worth being aware that the risk exists and discussing protective strategies.
Why Enteric Coating Does Not Solve the Problem
A common assumption is that enteric-coated aspirin, designed to dissolve in the intestine rather than the stomach, should spare the stomach lining. It makes intuitive sense: if the pill never touches the stomach, how can it cause damage there? The answer goes back to the systemic mechanism. Once the drug is absorbed into your bloodstream, it suppresses prostaglandins everywhere, including in the stomach wall. A systematic review examining multiple studies found that enteric-coated aspirin was not an effective strategy for gastrointestinal protection.4PubMed Central. Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review Direct comparison trials have confirmed that the coating shifts where the drug is released but does not meaningfully reduce ulcer rates.5Gastroenterology. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: A double-blind trial
This is one of the most persistent misconceptions in over-the-counter medicine. If you have been buying enteric-coated aspirin specifically to protect your stomach, the evidence says it is not doing what you think.
Do COX-2 Inhibitors Cause Fewer Stomach Problems?
The enzyme system that NSAIDs block actually comes in two main forms. One is more involved in protecting the stomach lining; the other is more involved in inflammation and pain signaling. Traditional NSAIDs like ibuprofen and naproxen block both forms indiscriminately. COX-2 selective inhibitors like celecoxib were designed to target the inflammation-related form while largely sparing the protective one.
Head-to-head trials bear this out, to a degree. In a large randomized trial comparing celecoxib to traditional NSAIDs, the rate of upper GI ulcer complications combined with symptomatic ulcers was lower in the celecoxib group, particularly among patients not also taking aspirin.6JAMA. Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis: The CLASS Study: A Randomized Controlled Trial An endoscopy study found that about 3 percent of celecoxib-treated subjects developed ulcers, compared to roughly 18 percent of those on ibuprofen and 25 percent of those on naproxen.7Gastroenterology. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury Smaller trials have shown a similar pattern, with fewer upper GI events in celecoxib groups than in ibuprofen groups, though some of these differences did not reach statistical significance on their own.8PubMed Central. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial
The catch is that COX-2 inhibitors are not risk-free for the gut, and they come with their own cardiovascular concerns that limit who can safely take them. And once you add aspirin to a COX-2 inhibitor (as many patients on heart-protective therapy must), the GI advantage largely disappears. In the CLASS trial, GI complication rates in people taking celecoxib plus aspirin were virtually indistinguishable from those in people taking traditional NSAIDs plus aspirin.6JAMA. Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis: The CLASS Study: A Randomized Controlled Trial
Damage Below the Stomach
Most people associate NSAID side effects with the stomach and upper digestive tract, but the small intestine is also vulnerable, and damage there is harder to detect. NSAID enteropathy, as it is called, is common and mostly silent. In many cases, small intestinal erosions, ulcers, or increased intestinal permeability develop without any symptoms the person would notice.9PubMed Central. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury Occasionally, though, it leads to serious complications like significant bleeding, narrowing of the intestine, or perforation.
The process in the small intestine is different from what happens in the stomach. Researchers have described a multi-step cascade: NSAIDs first damage the protective phospholipid layer on intestinal cells, then injure the energy-producing structures within those cells, weakening the barriers between cells. Once those barriers loosen, bile acids, bacteria, and digestive enzymes slip through and trigger inflammation.10Intestinal Research. Non-steroidal anti-inflammatory drug-induced enteropathy Because this mechanism is distinct from what drives stomach damage, drugs that protect the stomach do not necessarily protect the small intestine, a point that becomes important when we look at acid-suppressing medications.
The Proton Pump Inhibitor Paradox
Proton pump inhibitors (PPIs) like omeprazole and esomeprazole are the standard recommendation for protecting the stomach when someone needs to take NSAIDs regularly. And for the stomach, they work well. A Cochrane review found that PPIs cut the rate of new NSAID-associated ulcers by about 70 percent compared to placebo.11PubMed Central. Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia An earlier meta-analysis of five trials reported similar numbers: ulcer rates of roughly 15 percent with PPIs versus 36 percent with placebo.12Clinical Gastroenterology and Hepatology. Proton Pump Inhibitors for Prevention of Nonsteroidal Anti-inflammatory Drug–Induced Gastroduodenal Toxicity PPIs have also shown they can heal existing NSAID-related ulcers even when the person keeps taking the NSAID.13PubMed Central. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage
Here is the twist: PPIs may actually make things worse in the small intestine. Research has found that PPIs significantly shift the populations of bacteria living in the gut, including an 80 percent reduction in certain beneficial bacteria in the upper small intestine. In animal models, these bacterial shifts made NSAID-induced small intestinal ulcers and bleeding significantly worse. When researchers restored the depleted bacteria through supplementation, the intestinal damage was prevented.14PubMed. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis PPI use is now considered an independent risk factor for NSAID-associated small intestinal injury.15PubMed. Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine
This does not mean you should refuse a PPI if your doctor prescribes one alongside an NSAID. The stomach risks that PPIs prevent, especially bleeding ulcers, are more immediately dangerous than the small intestinal changes they may worsen. But it does highlight that there is no free lunch when it comes to gut protection, and researchers are actively exploring whether probiotic strategies could offset the intestinal downside.16PubMed Central. Gut Microbiota in NSAID Enteropathy: New Insights From Inside
How Opioids Affect the Gut Differently
Opioid painkillers like oxycodone, morphine, and hydrocodone do not cause ulcers the way NSAIDs do, but they create a different set of stomach problems. Opioids slow the entire digestive tract. They reduce the contractions that move food through the stomach and intestines, which can cause nausea, vomiting, bloating, severe constipation, and a condition where the stomach essentially stops emptying properly.
A study of patients with gastroparesis (delayed stomach emptying) found that opioid users had significantly worse scores for nausea, vomiting, bloating, abdominal pain, and constipation compared to non-users. They also had greater gastric retention, worse quality of life, and more hospitalizations. Stronger opioids were associated with worse outcomes than weaker ones like tramadol or codeine.17PubMed Central. Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis These effects can be severe enough to mimic other gastrointestinal conditions, making diagnosis tricky for doctors who may not immediately connect a patient’s stomach complaints to their pain medication.
When an Infection Makes the Drug More Dangerous
Helicobacter pylori is a bacterium that infects the stomach lining of a large share of the global population. On its own, it raises ulcer risk. NSAIDs on their own raise ulcer risk. Together, the two risk factors do not simply add up; they multiply. A case-control study found that having both an H. pylori infection and a history of ulcer bleeding, combined with NSAID use, was associated with a roughly tenfold increase in the odds of ulcer bleeding compared to people with neither risk factor.18Gastroenterology. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study
The practical takeaway is that eliminating H. pylori before starting long-term NSAID treatment reduces the occurrence of ulcers.19PubMed. Helicobacter pylori infection and the use of NSAIDs If you are going to be on an NSAID regularly, testing for and treating H. pylori is a relatively simple step that can meaningfully reduce your risk. This is something to bring up with your doctor, especially if you have a history of stomach problems or live in a region where H. pylori is common.
Drug Combinations That Multiply Bleeding Risk
Taking an NSAID alongside a blood thinner like warfarin roughly doubles the odds of gastrointestinal bleeding compared to warfarin alone. A systematic review and meta-analysis found the odds ratio for GI bleeding was about 2.0 for the combination. Even pairing warfarin with a COX-2 inhibitor, which is supposed to be gentler on the stomach, produced a nearly identical increase in bleeding risk.20PubMed Central. Risk of Bleeding with Exposure to Warfarin and Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review and Meta-Analysis This is why doctors are cautious about combining pain medications with anticoagulants, and why patients on blood thinners should avoid reaching for over-the-counter ibuprofen or naproxen without checking first.
Corticosteroids and selective serotonin reuptake inhibitors (SSRIs, a class of antidepressant) are other commonly prescribed drugs that, when combined with NSAIDs, can amplify GI bleeding risk. People often do not think of their antidepressant as relevant to a conversation about stomach bleeding, but the interaction is real. A careful assessment of all medications a patient is taking should happen before starting any NSAID.21PubMed Central. Treatment and chemoprevention of NSAID-associated gastrointestinal complications
Topical Pain Relievers as a Workaround
If you need an anti-inflammatory drug for joint or muscle pain but want to minimize gut exposure, topical formulations are worth considering. Applying diclofenac as a gel or solution to the skin over a painful joint delivers the drug locally with much less reaching the bloodstream. A pooled safety analysis comparing topical diclofenac to oral diclofenac found that GI side effects occurred in about 25 percent of topical users versus 39 percent of oral users.22PubMed Central. Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis The topical route does not eliminate GI risk entirely, since some drug is still absorbed systemically, but the reduction is meaningful. Topical NSAIDs work best for superficial joints like hands and knees; they are less effective for deep structures like the hip or lower back, where the drug cannot penetrate as well through overlying tissue.
Why Some People Get Ulcers and Others Do Not
You may know someone who has taken ibuprofen daily for years with no apparent problems, while someone else develops a bleeding ulcer within weeks. Part of this comes down to the obvious risk factors: age over 65, prior ulcer history, concurrent medications, and alcohol use. But genetics play a role too. The liver enzyme that metabolizes many NSAIDs has genetic variants that cause some people to break the drug down more slowly, keeping blood levels higher for longer. One such variant has been identified as a robust risk factor for acute upper gastrointestinal bleeding in NSAID users.23PubMed. CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin A separate case-control study confirmed that carrying this particular variant increases the risk of upper GI bleeding associated with NSAID use, particularly at higher doses.24PubMed Central. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study
Pharmacogenomic testing for these variants is available but not routinely done before prescribing NSAIDs. It is more commonly ordered in other contexts, like warfarin dosing. As testing becomes cheaper and more accessible, it may eventually become standard practice to check before putting someone on long-term NSAID therapy. In the meantime, if you have ever had an unusually severe reaction to a common NSAID, it could be worth asking your doctor whether genetic factors might be at play.
The Over-the-Counter Blind Spot
Because ibuprofen and naproxen are available without a prescription, many people treat them as essentially harmless. Case reports from clinical settings continue to document patients who self-medicated with over-the-counter NSAIDs for extended periods and developed severe peptic ulcers with life-threatening anemia.25Proceeding ISETH (International Summit on Science, Technology, and Humanity). Case Report: Peptic Ulcer and Anemia Gravis Due to Over-the-Counter Anti-Inflammatory Drugs Misuse in Gout Arthritis The availability of a drug without a prescription does not mean it is safe for long-term, unsupervised use. Taking ibuprofen for a headache once in a while is very different from taking it daily for chronic joint pain, but the packaging does not always make that distinction clear.
If you find yourself reaching for an NSAID most days of the week, that is the point at which it makes sense to have a conversation with a healthcare provider about alternatives, protective strategies, or whether the medication is even the best fit for what you are treating. Acetaminophen (paracetamol), for example, does not carry the same GI risks as NSAIDs, though it is less effective for inflammation and has its own ceiling with liver safety. The landscape of options is wider than most people realize, and matching the right pain medication to your particular risk profile can make the difference between manageable discomfort and a medical emergency.